TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer

BACKGROUND: Targeting protein for Xenopus kinesin-like protein 2 (TPX2) overexpression in human tumours is associated with increased malignancy. Its effect on gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC) has not been studied yet. METHODS: The prognostic impact of TPX2 expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Guenther, Michael, Surendran, Sai Agash, Haas, Michael, Heinemann, Volker, von Bergwelt-Baildon, Michael, Engel, Jutta, Werner, Jens, Boeck, Stefan, Ormanns, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307892/
https://www.ncbi.nlm.nih.gov/pubmed/37142730
http://dx.doi.org/10.1038/s41416-023-02295-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307892/
https://www.ncbi.nlm.nih.gov/pubmed/37142730
http://dx.doi.org/10.1038/s41416-023-02295-x

Ejemplares similares